O'Keeffe Charles B
Insider CIK 1378656 · CPRX Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 208,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2025-02-14 | 2025-02-19 | 4,000 | — | $0 | 732,470 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 212,274 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-27 | 2024-12-31 | 1,333 | — | $0 | 728,470 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-10 | 2024-12-11 | 40,000 | — | $0 | 213,607 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-10 | 2024-12-11 | 40,000 | $4.01 | $160.4K | 727,137 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 253,607 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-12-09 | 2024-12-11 | 1,413 | — | $0 | 687,137 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 2,841 | — | $0 | 255,020 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2024-11-21 | 2024-11-25 | 23,248 | — | $0 | 252,179 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 228,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-02-15 | 2024-02-16 | 4,000 | — | $0 | 685,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2024-01-02 | 2024-01-03 | 60,000 | — | $0 | 232,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2024-01-02 | 2024-01-03 | 60,000 | $1.13 | $67.8K | 681,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 292,931 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-12-27 | 2023-12-29 | 1,333 | — | $0 | 621,724 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 29,524 | — | $0 | 290,024 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2023-12-08 | 2023-12-12 | 4,240 | — | $0 | 294,264 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 260,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-02-15 | 2023-02-17 | 4,000 | — | $0 | 620,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2023-01-24 | 2023-01-27 | 50,000 | — | $0 | 264,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2023-01-24 | 2023-01-27 | 50,000 | $0.79 | $39.5K | 616,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 15,000 | — | $0 | 310,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-12-27 | 2022-12-29 | 4,000 | — | $0 | 314,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 295,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-12-06 | 2022-12-08 | 1,334 | — | $0 | 566,391 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | S Sale | 2022-11-15 | 2022-11-17 | 87,985 | $16.04 | $1.41M | 565,057 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2022-08-18 | 2022-08-19 | 40,000 | — | $0 | 296,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2022-08-18 | 2022-08-19 | 40,000 | $2.53 | $101.2K | 653,042 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2022-02-14 | 2022-02-16 | 12,000 | — | $0 | 336,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2021-12-28 | 2021-12-30 | 20,000 | — | $0 | 324,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 304,834 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-12-03 | 2021-12-06 | 1,333 | — | $0 | 613,042 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2021-08-16 | 2021-08-17 | 50,000 | — | $0 | 306,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2021-08-16 | 2021-08-17 | 50,000 | $3.12 | $156.0K | 611,709 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2020-12-30 | 2021-01-04 | 30,000 | — | $0 | 356,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2020-12-22 | 2020-12-23 | 1,333 | — | $0 | 326,167 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2020-12-22 | 2020-12-23 | 1,333 | — | $0 | 561,709 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2020-09-30 | 2020-09-30 | 7,000 | $2.99 | $20.9K | 560,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 4,000 | — | $0 | 327,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2019-12-02 | 2019-12-04 | 33,500 | — | $0 | 323,500 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2019-10-11 | 2019-10-11 | 10,000 | $4.70 | $47.0K | 553,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 290,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-12-19 | 2018-12-21 | 25,000 | — | $0 | 265,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-12-14 | 2018-12-14 | 20,000 | $2.50 | $50.0K | 543,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-06-07 | 2018-06-07 | 4,000 | $3.31 | $13.2K | 522,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-06-07 | 2018-06-08 | 1,000 | $3.35 | $3.4K | 523,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2018-06-01 | 2018-06-01 | 5,000 | $3.74 | $18.7K | 518,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 240,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2018-01-02 | 2018-01-04 | 20,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2017-11-16 | 2017-11-17 | 50,000 | — | $0 | 145,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-11-16 | 2017-11-17 | 50,000 | $0.47 | $23.5K | 513,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | X Exercise deriv | 2017-05-11 | 2017-05-15 | 31,250 | $0.80 | $25.0K | 0 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2017-05-11 | 2017-05-15 | 31,250 | $1.04 | $32.5K | 463,376 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 250,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2017-01-03 | 2017-01-05 | 30,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-07-12 | 2016-07-12 | 20,000 | $0.81 | $16.2K | 432,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 195,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2016-06-15 | 2016-06-17 | 25,000 | — | $0 | 220,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-04-26 | 2016-04-27 | 20,000 | $0.60 | $12.0K | 412,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-03-16 | 2016-03-16 | 10,000 | $1.11 | $11.1K | 392,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-02-01 | 2016-02-01 | 5,000 | $1.87 | $9.3K | 382,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2016-01-08 | 2016-01-11 | 5,000 | $1.94 | $9.7K | 377,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 150,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | A Award deriv | 2015-12-30 | 2016-01-04 | 20,000 | — | $0 | 170,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2015-12-23 | 2015-12-23 | 5,000 | $2.41 | $12.1K | 372,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2015-11-19 | 2015-11-19 | 5,000 | $2.30 | $11.5K | 367,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | P Buy | 2015-10-01 | 2015-10-01 | 10,000 | $2.85 | $28.5K | 362,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise deriv | 2015-08-25 | 2015-08-26 | 30,000 | — | $0 | 130,000 | SEC↗ |
| CPRX CATALYST PHARMACEUTICALS, | M Exercise | 2015-08-25 | 2015-08-26 | 30,000 | $1.09 | $32.7K | 352,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-04-30 | 2015-04-30 | 10,000 | $3.29 | $32.9K | 322,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-04-24 | 2015-04-24 | 5,000 | $3.80 | $19.0K | 312,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2015-01-13 | 2015-01-13 | 10,000 | $3.00 | $30.0K | 307,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise deriv | 2014-10-02 | 2014-10-03 | 105,000 | — | $0 | 191,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | M Exercise | 2014-10-02 | 2014-10-03 | 105,000 | $0.90 | $94.5K | 297,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 25,000 | — | $0 | 296,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2014-08-28 | 2014-09-02 | 25,000 | — | $0 | 271,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2014-05-19 | 2014-05-21 | 10,000 | $1.83 | $18.3K | 192,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2014-04-16 | 2014-04-17 | 5,000 | $2.02 | $10.1K | 182,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2014-02-05 | 2014-02-06 | 10,000 | $1.81 | $18.1K | 177,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2013-10-21 | 2013-10-21 | 10,000 | $1.84 | $18.4K | 167,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | A Award deriv | 2012-12-12 | 2012-12-14 | 50,000 | — | $0 | 261,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-11-15 | 2012-11-15 | 25,000 | $0.42 | $10.5K | 157,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-06-01 | 2012-06-01 | 20,000 | $0.57 | $11.4K | 132,126 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy deriv | 2012-05-24 | 2012-05-29 | 31,250 | — | $0 | 211,250 | SEC↗ |
| CPRX CATALYST PHARMACEUTICAL PA | P Buy | 2012-05-24 | 2012-05-29 | 31,250 | $0.80 | $25.0K | 112,126 | SEC↗ |